Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Let’s Define Undifferentiated Connective Tissue Disease

Lucy Masto, BS, Medha Barbhaiya, MD, MPH, Caroline H. Siegel, MD, MS, Lisa R. Sammaritano, MD, & Michael D. Lockshin, MD  |  Issue: August 2024  |  August 6, 2024


Lucy Masto, BS, is a clinical research assistant at the Hospital for Special Surgery, New York.

Medha Barbhaiya, MD, MPH, is a rheumatologist and clinical researcher at the Hospital for Special Surgery and Weill Cornell Medicine, New York.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Caroline H. Siegel, MD, MS, is a rheumatologist and clinical researcher at the Hospital for Special Surgery and Weill Cornell Medicine, New York.

Lisa R. Sammaritano, MD, is the director of the Rheumatology Reproductive Health Program at the Barbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery, and professor of clinical medicine at Weill Cornell Medicine, New York.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Michael D. Lockshin, MD, is director emeritus of the Barbara Volcker Center for Women and Rheumatic Diseases at the Hospital for Special Surgery, New York. He served as editor in chief of Arthritis & Rheumatism and has been recognized with national awards from the Arthritis Foundation, the ACR and the Lupus Foundation of America.

References

  1. Leroy EC, Maricq HR, Kahaleh MB. Undifferentiated connective tissue syndromes. Arthritis Rheum. 1980 Mar;23(3):341–343.
  2. Ugarte‐Gil MF, Alarcón GS. Incomplete systemic lupus erythematosus: Early diagnosis or overdiagnosis? Arthritis Care Res (Hoboken). 2016 Mar;68(3):285–287.
  3. Drehmel KR, Erickson AR, England BR, et al. Applying SLICC and ACR/EULAR systemic lupus erythematosus classification criteria in a cohort of patients with undifferentiated connective tissue disease. Lupus. 2021 Feb;30(2):280–284.
  4. Antunes M, Scirè CA, Talarico R, et al. Undifferentiated connective tissue disease: State of the art on clinical practice guidelines. RMD Open. 2019 Feb;4(Suppl 1):e000786.
  5. Sciascia S, Roccatello D, Radin M, et al. Differentiating between UCTD and early-stage SLE: From definitions to clinical approach. Nat Rev Rheumatol. 2022 Jan;18(1):9–21.
  6. Mosca M, Neri R, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): A review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol. 1999;17(5):615–620.
  7. Marwa K, Anjum F. Undifferentiated Connective Tissue Disease. Treasure Island (FL): StatPearls Publishing; 2023 Apr 27.
  8. Jia L, Levine AB, Lockshin MD. American College of Rheumatology criteria for systemic lupus erythematosus exclude half of all systemic lupus erythematosus patients. Arthritis Rheumatol. 2017 Jul;69(7):1502–1503.
  9. Lockshin MD, Crow MK, Barbhaiya M. When a diagnosis has no name: Uncertainty and opportunity. ACR Open Rheumatol. 2022 Mar;4(3):197–201.
  10. Siegel CH, Kleinman J, Barbhaiya M, et al. The psychosocial impact of undifferentiated connective tissue disease on patient health and well-being: A qualitative study. J Clin Rheumatol. 2022 Mar;28(2):e340–e347.
  11. Mosca M, Tani C, Vagnani S, et al. The diagnosis and classification of undifferentiated connective tissue diseases. J Autoimmun. 2014 Feb–Mar;48–49:50–52.
  12. Iudici M, Irace R, Riccardi A, et al. Longitudinal analysis of quality of life in patients with undifferentiated connective tissue diseases. Patient Relat Outcome Meas. 2017 Feb;8:7–13.
  13. Rubio J, Kyttaris VC. Undifferentiated connective tissue disease: Comprehensive review. Curr Rheumatol Rep. 2023 May;25(5):98–106.
  14. García-González M, Rodríguez-Lozano B, Bustabad S, et al. Undifferentiated connective tissue disease: Predictors of evolution into definite disease. Clin Exp Rheumatol. 2017 Sep–Oct;35(5):739–745.
  15. Dyball S, Rodziewicz M, Mendoza-Pinto C, et al. Predicting progression from undifferentiated connective tissue disease to definite connective tissue disease: A systematic review and meta-analysis. Autoimmun Rev. 2022 Nov;21(11):103184.
  16. Siegel CH, Stamm B, Vega J, Lockshin MD, et al. Characteristics of patients diagnosed with undifferentiated connective tissue disease [AB0556]. Ann Rheum Dis. 2022;81(Suppl 1):1405.1–1405.
  17. Lockshin MD, Crow MK, Barbhaiya M, eds. Diagnoses Without Names: Challenges for Medical Care, Research, and Policy. Cham, Switzerland: Springer International Publishing; 2022.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsGuidanceGuidelinesOpinionOther Rheumatic ConditionsSjögren’s DiseaseSystemic Lupus Erythematosus Tagged with:clinical criteriaconnective tissue diseaseDiagnostic CriteriaSLE Resource Centerundifferentiated connective tissue disease (UCTD)

Related Articles

    What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)

    December 1, 2012

    Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)
     

    The Key to Early Rheumatoid Arthritis

    September 1, 2010

    The conundrum of classification versus diagnosis

    Interferon Score Predicts AI-CTDs

    November 18, 2018

    People with autoimmune connective tissue diseases produce antibodies against nuclear antigens up to 10 years before they develop clinical features. Anti-nuclear antibodies (ANAs) are also very common, and a small percentage of ANA-positive patients progress to clinical autoimmunity. The question: Is there a reliable way to screen at-risk patients before they develop active autoimmunity and…

    Laboratory Testing for Diagnosis, Management of Patients with Rheumatic Disease

    December 1, 2014

    A review of data on antinuclear antibodies and tests for rheumatoid arthritis

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences